Pharmacologic Treatment for Temporomandibular and Temporomandibular Joint Disorders.

Oral and maxillofacial surgery clinics of North America 2022 Vol.34(1) p. 49-59

Andre A, Kang J, Dym H

관련 도메인

Abstract

Temporomandibular joint disorder is defined by pain and/or loss of function of the temporomandibular joint and its associated muscles and structures. Treatments include noninvasive pharmacologic therapies, minimally invasive muscular and articular injections, and surgery. Conservative therapies include nonsteroidal anti-inflammatory drugs, muscle relaxants, benzodiazepines, antidepressants, and anticonvulsants. Minimally invasive injections include botulinum toxin, corticosteroids, platelet-rich plasma, hyaluronic acid, and prolotherapy with hypertonic glucose. With many pharmacologic treatment options and modalities available to the oral and maxillofacial surgeon, mild to moderate temporomandibular joint disorder can be managed safely and effectively to improve symptoms of pain and function of the temporomandibular joint.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
재료 hyaluronic acid 히알루론산 dict 1

MeSH Terms

Anticonvulsants; Humans; Hyaluronic Acid; Injections, Intra-Articular; Temporomandibular Joint; Temporomandibular Joint Disorders

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문